Eisai Co., Ltd.
Eisai Co., Ltd. (ESALY) Stock Competitors & Peer Comparison
See (ESALY) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| ESALY | $61.51 | -2.11% | 17.6B | 20.54 | $3.00 | N/A |
| MKKGY | $26.11 | +3.61% | 56.9B | 17.08 | $1.53 | +1.91% |
| MKGAF | $130.35 | +3.08% | 55.2B | 16.53 | $7.68 | +1.97% |
| TKPHF | $27.50 | -3.71% | 44.6B | 49.24 | $0.58 | +4.66% |
| HLNCF | $4.95 | +4.32% | 44.5B | 23.57 | $0.21 | +1.76% |
| IPSEY | $31.14 | +0.26% | 41.2B | 19.83 | $1.57 | +0.83% |
| SDZNY | $59.31 | +2.36% | 25.5B | 114.04 | $0.52 | +1.14% |
| TEVJF | $14.00 | -2.23% | 16.4B | -95.47 | -$0.15 | N/A |
| SGIOY | $9.07 | +1.34% | 15.5B | 13.35 | $0.68 | +1.76% |
| SGIOF | $16.79 | +0.00% | 14.3B | 12.35 | $1.36 | +4.84% |
Stock Comparison
ESALY vs MKKGY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, MKKGY has a market cap of 56.9B. Regarding current trading prices, ESALY is priced at $61.51, while MKKGY trades at $26.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas MKKGY's P/E ratio is 17.08. In terms of profitability, ESALY's ROE is +0.06%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, ESALY is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check MKKGY's competition here
ESALY vs MKGAF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, MKGAF has a market cap of 55.2B. Regarding current trading prices, ESALY is priced at $61.51, while MKGAF trades at $130.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas MKGAF's P/E ratio is 16.53. In terms of profitability, ESALY's ROE is +0.06%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, ESALY is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check MKGAF's competition here
ESALY vs TKPHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TKPHF has a market cap of 44.6B. Regarding current trading prices, ESALY is priced at $61.51, while TKPHF trades at $27.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TKPHF's P/E ratio is 49.24. In terms of profitability, ESALY's ROE is +0.06%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, ESALY is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check TKPHF's competition here
ESALY vs HLNCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HLNCF has a market cap of 44.5B. Regarding current trading prices, ESALY is priced at $61.51, while HLNCF trades at $4.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HLNCF's P/E ratio is 23.57. In terms of profitability, ESALY's ROE is +0.06%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, ESALY is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check HLNCF's competition here
ESALY vs IPSEY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, IPSEY has a market cap of 41.2B. Regarding current trading prices, ESALY is priced at $61.51, while IPSEY trades at $31.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas IPSEY's P/E ratio is 19.83. In terms of profitability, ESALY's ROE is +0.06%, compared to IPSEY's ROE of +0.08%. Regarding short-term risk, ESALY is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check IPSEY's competition here
ESALY vs SDZNY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SDZNY has a market cap of 25.5B. Regarding current trading prices, ESALY is priced at $61.51, while SDZNY trades at $59.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SDZNY's P/E ratio is 114.04. In terms of profitability, ESALY's ROE is +0.06%, compared to SDZNY's ROE of +0.00%. Regarding short-term risk, ESALY is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SDZNY's competition here
ESALY vs TEVJF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TEVJF has a market cap of 16.4B. Regarding current trading prices, ESALY is priced at $61.51, while TEVJF trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TEVJF's P/E ratio is -95.47. In terms of profitability, ESALY's ROE is +0.06%, compared to TEVJF's ROE of -0.03%. Regarding short-term risk, ESALY is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check TEVJF's competition here
ESALY vs SGIOY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SGIOY has a market cap of 15.5B. Regarding current trading prices, ESALY is priced at $61.51, while SGIOY trades at $9.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SGIOY's P/E ratio is 13.35. In terms of profitability, ESALY's ROE is +0.06%, compared to SGIOY's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SGIOY's competition here
ESALY vs SGIOF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SGIOF has a market cap of 14.3B. Regarding current trading prices, ESALY is priced at $61.51, while SGIOF trades at $16.79.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SGIOF's P/E ratio is 12.35. In terms of profitability, ESALY's ROE is +0.06%, compared to SGIOF's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SGIOF's competition here
ESALY vs BIOVF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, BIOVF has a market cap of 10B. Regarding current trading prices, ESALY is priced at $61.51, while BIOVF trades at $28.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas BIOVF's P/E ratio is 21.95. In terms of profitability, ESALY's ROE is +0.06%, compared to BIOVF's ROE of +0.11%. Regarding short-term risk, ESALY is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check BIOVF's competition here
ESALY vs IPSEF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, ESALY is priced at $61.51, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, ESALY's ROE is +0.06%, compared to IPSEF's ROE of +0.08%. Regarding short-term risk, ESALY is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check IPSEF's competition here
ESALY vs SFOSF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SFOSF has a market cap of 8.8B. Regarding current trading prices, ESALY is priced at $61.51, while SFOSF trades at $2.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SFOSF's P/E ratio is 15.33. In terms of profitability, ESALY's ROE is +0.06%, compared to SFOSF's ROE of +0.06%. Regarding short-term risk, ESALY is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SFOSF's competition here
ESALY vs ESALF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, ESALF has a market cap of 8.7B. Regarding current trading prices, ESALY is priced at $61.51, while ESALF trades at $31.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas ESALF's P/E ratio is 27.93. In terms of profitability, ESALY's ROE is +0.06%, compared to ESALF's ROE of +0.03%. Regarding short-term risk, ESALY is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check ESALF's competition here
ESALY vs ESAIY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, ESAIY has a market cap of 8.6B. Regarding current trading prices, ESALY is priced at $61.51, while ESAIY trades at $7.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas ESAIY's P/E ratio is 27.25. In terms of profitability, ESALY's ROE is +0.06%, compared to ESAIY's ROE of +0.03%. Regarding short-term risk, ESALY is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check ESAIY's competition here
ESALY vs GZPHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, ESALY is priced at $61.51, while GZPHF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas GZPHF's P/E ratio is 10.22. In terms of profitability, ESALY's ROE is +0.06%, compared to GZPHF's ROE of +0.07%. Regarding short-term risk, ESALY is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check GZPHF's competition here
ESALY vs HKMPY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HKMPY has a market cap of 5.3B. Regarding current trading prices, ESALY is priced at $61.51, while HKMPY trades at $51.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HKMPY's P/E ratio is 14.45. In terms of profitability, ESALY's ROE is +0.06%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, ESALY is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HKMPY's competition here
ESALY vs HKMPF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HKMPF has a market cap of 5.3B. Regarding current trading prices, ESALY is priced at $61.51, while HKMPF trades at $26.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HKMPF's P/E ratio is 14.35. In terms of profitability, ESALY's ROE is +0.06%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, ESALY is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HKMPF's competition here
ESALY vs SGFEF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SGFEF has a market cap of 5.2B. Regarding current trading prices, ESALY is priced at $61.51, while SGFEF trades at $114.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SGFEF's P/E ratio is 25.02. In terms of profitability, ESALY's ROE is +0.06%, compared to SGFEF's ROE of +0.17%. Regarding short-term risk, ESALY is more volatile compared to SGFEF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SGFEF's competition here
ESALY vs WIBFF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, WIBFF has a market cap of 5B. Regarding current trading prices, ESALY is priced at $61.51, while WIBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas WIBFF's P/E ratio is -0.01. In terms of profitability, ESALY's ROE is +0.06%, compared to WIBFF's ROE of +0.00%. Regarding short-term risk, ESALY is more volatile compared to WIBFF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check WIBFF's competition here
ESALY vs HLBBF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HLBBF has a market cap of 4.4B. Regarding current trading prices, ESALY is priced at $61.51, while HLBBF trades at $5.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HLBBF's P/E ratio is 10.61. In terms of profitability, ESALY's ROE is +0.06%, compared to HLBBF's ROE of +0.14%. Regarding short-term risk, ESALY is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HLBBF's competition here
ESALY vs HLUBF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HLUBF has a market cap of 4.3B. Regarding current trading prices, ESALY is priced at $61.51, while HLUBF trades at $4.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HLUBF's P/E ratio is 8.83. In terms of profitability, ESALY's ROE is +0.06%, compared to HLUBF's ROE of +0.14%. Regarding short-term risk, ESALY is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HLUBF's competition here
ESALY vs SMDPY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SMDPY has a market cap of 3.9B. Regarding current trading prices, ESALY is priced at $61.51, while SMDPY trades at $9.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SMDPY's P/E ratio is 24.38. In terms of profitability, ESALY's ROE is +0.06%, compared to SMDPY's ROE of +0.15%. Regarding short-term risk, ESALY is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SMDPY's competition here
ESALY vs LVZPF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LVZPF has a market cap of 3.5B. Regarding current trading prices, ESALY is priced at $61.51, while LVZPF trades at $3.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LVZPF's P/E ratio is 11.43. In terms of profitability, ESALY's ROE is +0.06%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, ESALY is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LVZPF's competition here
ESALY vs CHSYF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, ESALY is priced at $61.51, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CHSYF's P/E ratio is 15.00. In terms of profitability, ESALY's ROE is +0.06%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, ESALY is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check CHSYF's competition here
ESALY vs ULIHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, ULIHF has a market cap of 3.2B. Regarding current trading prices, ESALY is priced at $61.51, while ULIHF trades at $1.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas ULIHF's P/E ratio is 8.20. In terms of profitability, ESALY's ROE is +0.06%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, ESALY is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check ULIHF's competition here
ESALY vs APNHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, APNHF has a market cap of 3.2B. Regarding current trading prices, ESALY is priced at $61.51, while APNHF trades at $7.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas APNHF's P/E ratio is 12.72. In terms of profitability, ESALY's ROE is +0.06%, compared to APNHF's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check APNHF's competition here
ESALY vs INVVY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, ESALY is priced at $61.51, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas INVVY's P/E ratio is -62.42. In terms of profitability, ESALY's ROE is +0.06%, compared to INVVY's ROE of -0.48%. Regarding short-term risk, ESALY is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check INVVY's competition here
ESALY vs IZQVF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, ESALY is priced at $61.51, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, ESALY's ROE is +0.06%, compared to IZQVF's ROE of -0.48%. Regarding short-term risk, ESALY is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check IZQVF's competition here
ESALY vs DNPUF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, DNPUF has a market cap of 2.9B. Regarding current trading prices, ESALY is priced at $61.51, while DNPUF trades at $7.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas DNPUF's P/E ratio is 18.10. In terms of profitability, ESALY's ROE is +0.06%, compared to DNPUF's ROE of +0.15%. Regarding short-term risk, ESALY is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check DNPUF's competition here
ESALY vs LBTSF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LBTSF has a market cap of 2.9B. Regarding current trading prices, ESALY is priced at $61.51, while LBTSF trades at $13.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LBTSF's P/E ratio is 121.45. In terms of profitability, ESALY's ROE is +0.06%, compared to LBTSF's ROE of +0.01%. Regarding short-term risk, ESALY is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LBTSF's competition here
ESALY vs APNHY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, APNHY has a market cap of 2.8B. Regarding current trading prices, ESALY is priced at $61.51, while APNHY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas APNHY's P/E ratio is 11.37. In terms of profitability, ESALY's ROE is +0.06%, compared to APNHY's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check APNHY's competition here
ESALY vs HMDCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HMDCF has a market cap of 2.8B. Regarding current trading prices, ESALY is priced at $61.51, while HMDCF trades at $3.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HMDCF's P/E ratio is -64.10. In terms of profitability, ESALY's ROE is +0.06%, compared to HMDCF's ROE of +0.03%. Regarding short-term risk, ESALY is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HMDCF's competition here
ESALY vs HYPMY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HYPMY has a market cap of 2.6B. Regarding current trading prices, ESALY is priced at $61.51, while HYPMY trades at $4.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HYPMY's P/E ratio is 18.50. In terms of profitability, ESALY's ROE is +0.06%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, ESALY is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check HYPMY's competition here
ESALY vs THCBF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, THCBF has a market cap of 2.4B. Regarding current trading prices, ESALY is priced at $61.51, while THCBF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas THCBF's P/E ratio is -0.10. In terms of profitability, ESALY's ROE is +0.06%, compared to THCBF's ROE of +0.00%. Regarding short-term risk, ESALY is more volatile compared to THCBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check THCBF's competition here
ESALY vs DMPHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, ESALY is priced at $61.51, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, ESALY's ROE is +0.06%, compared to DMPHF's ROE of +0.17%. Regarding short-term risk, ESALY is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check DMPHF's competition here
ESALY vs HTSUF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HTSUF has a market cap of 2.1B. Regarding current trading prices, ESALY is priced at $61.51, while HTSUF trades at $28.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HTSUF's P/E ratio is 15.99. In terms of profitability, ESALY's ROE is +0.06%, compared to HTSUF's ROE of +0.08%. Regarding short-term risk, ESALY is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HTSUF's competition here
ESALY vs CURLF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CURLF has a market cap of 2.1B. Regarding current trading prices, ESALY is priced at $61.51, while CURLF trades at $2.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CURLF's P/E ratio is -7.83. In terms of profitability, ESALY's ROE is +0.06%, compared to CURLF's ROE of -0.25%. Regarding short-term risk, ESALY is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check CURLF's competition here
ESALY vs LJUIF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LJUIF has a market cap of 2.1B. Regarding current trading prices, ESALY is priced at $61.51, while LJUIF trades at $0.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LJUIF's P/E ratio is 13.97. In terms of profitability, ESALY's ROE is +0.06%, compared to LJUIF's ROE of +0.15%. Regarding short-term risk, ESALY is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LJUIF's competition here
ESALY vs GTBIF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, GTBIF has a market cap of 1.9B. Regarding current trading prices, ESALY is priced at $61.51, while GTBIF trades at $8.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas GTBIF's P/E ratio is 74.27. In terms of profitability, ESALY's ROE is +0.06%, compared to GTBIF's ROE of +0.03%. Regarding short-term risk, ESALY is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check GTBIF's competition here
ESALY vs CASBF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CASBF has a market cap of 1.9B. Regarding current trading prices, ESALY is priced at $61.51, while CASBF trades at $6.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CASBF's P/E ratio is -29.81. In terms of profitability, ESALY's ROE is +0.06%, compared to CASBF's ROE of -0.04%. Regarding short-term risk, ESALY is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check CASBF's competition here
ESALY vs ARSUF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, ARSUF has a market cap of 1.8B. Regarding current trading prices, ESALY is priced at $61.51, while ARSUF trades at $25.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas ARSUF's P/E ratio is 22.70. In terms of profitability, ESALY's ROE is +0.06%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, ESALY is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check ARSUF's competition here
ESALY vs TSMRF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TSMRF has a market cap of 1.8B. Regarding current trading prices, ESALY is priced at $61.51, while TSMRF trades at $23.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TSMRF's P/E ratio is 8.21. In terms of profitability, ESALY's ROE is +0.06%, compared to TSMRF's ROE of +0.11%. Regarding short-term risk, ESALY is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check TSMRF's competition here
ESALY vs NPNKF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, NPNKF has a market cap of 1.7B. Regarding current trading prices, ESALY is priced at $61.51, while NPNKF trades at $25.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas NPNKF's P/E ratio is 7.82. In terms of profitability, ESALY's ROE is +0.06%, compared to NPNKF's ROE of +0.14%. Regarding short-term risk, ESALY is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check NPNKF's competition here
ESALY vs MITPF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, ESALY is priced at $61.51, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas MITPF's P/E ratio is -10.81. In terms of profitability, ESALY's ROE is +0.06%, compared to MITPF's ROE of +4.92%. Regarding short-term risk, ESALY is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check MITPF's competition here
ESALY vs KARBF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, ESALY is priced at $61.51, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas KARBF's P/E ratio is 262.50. In terms of profitability, ESALY's ROE is +0.06%, compared to KARBF's ROE of N/A. Regarding short-term risk, ESALY is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check KARBF's competition here
ESALY vs EVOTF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, EVOTF has a market cap of 1.5B. Regarding current trading prices, ESALY is priced at $61.51, while EVOTF trades at $8.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas EVOTF's P/E ratio is -6.22. In terms of profitability, ESALY's ROE is +0.06%, compared to EVOTF's ROE of -0.22%. Regarding short-term risk, ESALY is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check EVOTF's competition here
ESALY vs NPPNY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, NPPNY has a market cap of 1.4B. Regarding current trading prices, ESALY is priced at $61.51, while NPPNY trades at $5.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas NPPNY's P/E ratio is 6.55. In terms of profitability, ESALY's ROE is +0.06%, compared to NPPNY's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check NPPNY's competition here
ESALY vs SHEZF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SHEZF has a market cap of 1.4B. Regarding current trading prices, ESALY is priced at $61.51, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, ESALY's ROE is +0.06%, compared to SHEZF's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SHEZF's competition here
ESALY vs TCNNF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TCNNF has a market cap of 1.4B. Regarding current trading prices, ESALY is priced at $61.51, while TCNNF trades at $7.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TCNNF's P/E ratio is -9.09. In terms of profitability, ESALY's ROE is +0.06%, compared to TCNNF's ROE of -0.13%. Regarding short-term risk, ESALY is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check TCNNF's competition here
ESALY vs CHIZF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, ESALY is priced at $61.51, while CHIZF trades at $0.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CHIZF's P/E ratio is 13.75. In terms of profitability, ESALY's ROE is +0.06%, compared to CHIZF's ROE of +0.00%. Regarding short-term risk, ESALY is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check CHIZF's competition here
ESALY vs KSPHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, KSPHF has a market cap of 1.3B. Regarding current trading prices, ESALY is priced at $61.51, while KSPHF trades at $30.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas KSPHF's P/E ratio is 16.28. In terms of profitability, ESALY's ROE is +0.06%, compared to KSPHF's ROE of +0.06%. Regarding short-term risk, ESALY is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check KSPHF's competition here
ESALY vs GNMLF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, GNMLF has a market cap of 1.2B. Regarding current trading prices, ESALY is priced at $61.51, while GNMLF trades at $1.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas GNMLF's P/E ratio is 11.70. In terms of profitability, ESALY's ROE is +0.06%, compared to GNMLF's ROE of +0.12%. Regarding short-term risk, ESALY is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check GNMLF's competition here
ESALY vs SWGHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SWGHF has a market cap of 1.1B. Regarding current trading prices, ESALY is priced at $61.51, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, ESALY's ROE is +0.06%, compared to SWGHF's ROE of +0.12%. Regarding short-term risk, ESALY is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SWGHF's competition here
ESALY vs KKPCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, KKPCF has a market cap of 1.1B. Regarding current trading prices, ESALY is priced at $61.51, while KKPCF trades at $28.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas KKPCF's P/E ratio is 11.24. In terms of profitability, ESALY's ROE is +0.06%, compared to KKPCF's ROE of +0.09%. Regarding short-term risk, ESALY is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check KKPCF's competition here
ESALY vs BIOGY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, BIOGY has a market cap of 995.4M. Regarding current trading prices, ESALY is priced at $61.51, while BIOGY trades at $9.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas BIOGY's P/E ratio is 32.53. In terms of profitability, ESALY's ROE is +0.06%, compared to BIOGY's ROE of +0.18%. Regarding short-term risk, ESALY is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check BIOGY's competition here
ESALY vs NIKA Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, NIKA has a market cap of 972.7M. Regarding current trading prices, ESALY is priced at $61.51, while NIKA trades at $0.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas NIKA's P/E ratio is N/A. In terms of profitability, ESALY's ROE is +0.06%, compared to NIKA's ROE of +0.39%. Regarding short-term risk, ESALY is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check NIKA's competition here
ESALY vs SHPHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SHPHF has a market cap of 924.4M. Regarding current trading prices, ESALY is priced at $61.51, while SHPHF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SHPHF's P/E ratio is -3.33. In terms of profitability, ESALY's ROE is +0.06%, compared to SHPHF's ROE of -0.05%. Regarding short-term risk, ESALY is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SHPHF's competition here
ESALY vs LVTTF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LVTTF has a market cap of 890.3M. Regarding current trading prices, ESALY is priced at $61.51, while LVTTF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LVTTF's P/E ratio is -0.02. In terms of profitability, ESALY's ROE is +0.06%, compared to LVTTF's ROE of +0.00%. Regarding short-term risk, ESALY is more volatile compared to LVTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LVTTF's competition here
ESALY vs EVRRF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, EVRRF has a market cap of 886.5M. Regarding current trading prices, ESALY is priced at $61.51, while EVRRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas EVRRF's P/E ratio is -0.08. In terms of profitability, ESALY's ROE is +0.06%, compared to EVRRF's ROE of +2.97%. Regarding short-term risk, ESALY is more volatile compared to EVRRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check EVRRF's competition here
ESALY vs NRXCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, NRXCF has a market cap of 841.1M. Regarding current trading prices, ESALY is priced at $61.51, while NRXCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas NRXCF's P/E ratio is -0.22. In terms of profitability, ESALY's ROE is +0.06%, compared to NRXCF's ROE of +2.32%. Regarding short-term risk, ESALY is more volatile compared to NRXCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check NRXCF's competition here
ESALY vs TWAPF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, ESALY is priced at $61.51, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, ESALY's ROE is +0.06%, compared to TWAPF's ROE of +0.11%. Regarding short-term risk, ESALY is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check TWAPF's competition here
ESALY vs CSWYF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, ESALY is priced at $61.51, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, ESALY's ROE is +0.06%, compared to CSWYF's ROE of +0.04%. Regarding short-term risk, ESALY is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check CSWYF's competition here
ESALY vs TRXPF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TRXPF has a market cap of 690.8M. Regarding current trading prices, ESALY is priced at $61.51, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, ESALY's ROE is +0.06%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, ESALY is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check TRXPF's competition here
ESALY vs YIHCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, ESALY is priced at $61.51, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, ESALY's ROE is +0.06%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, ESALY is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check YIHCF's competition here
ESALY vs ELTP Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, ELTP has a market cap of 608.2M. Regarding current trading prices, ESALY is priced at $61.51, while ELTP trades at $0.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas ELTP's P/E ratio is -28.40. In terms of profitability, ESALY's ROE is +0.06%, compared to ELTP's ROE of -0.09%. Regarding short-term risk, ESALY is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check ELTP's competition here
ESALY vs TRSSF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, ESALY is priced at $61.51, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, ESALY's ROE is +0.06%, compared to TRSSF's ROE of -0.32%. Regarding short-term risk, ESALY is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check TRSSF's competition here
ESALY vs SWDCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, SWDCF has a market cap of 600.2M. Regarding current trading prices, ESALY is priced at $61.51, while SWDCF trades at $4.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas SWDCF's P/E ratio is 93.88. In terms of profitability, ESALY's ROE is +0.06%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, ESALY is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check SWDCF's competition here
ESALY vs AIHLF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, AIHLF has a market cap of 566M. Regarding current trading prices, ESALY is priced at $61.51, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas AIHLF's P/E ratio is 12.50. In terms of profitability, ESALY's ROE is +0.06%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, ESALY is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check AIHLF's competition here
ESALY vs PKBFF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, ESALY is priced at $61.51, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas PKBFF's P/E ratio is N/A. In terms of profitability, ESALY's ROE is +0.06%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, ESALY is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check PKBFF's competition here
ESALY vs CCHWF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, ESALY is priced at $61.51, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, ESALY's ROE is +0.06%, compared to CCHWF's ROE of -7.05%. Regarding short-term risk, ESALY is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check CCHWF's competition here
ESALY vs GLASF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, GLASF has a market cap of 485.7M. Regarding current trading prices, ESALY is priced at $61.51, while GLASF trades at $6.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas GLASF's P/E ratio is -76.44. In terms of profitability, ESALY's ROE is +0.06%, compared to GLASF's ROE of +0.07%. Regarding short-term risk, ESALY is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check GLASF's competition here
ESALY vs KHTRF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, KHTRF has a market cap of 464.4M. Regarding current trading prices, ESALY is priced at $61.51, while KHTRF trades at $4.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas KHTRF's P/E ratio is 66.57. In terms of profitability, ESALY's ROE is +0.06%, compared to KHTRF's ROE of +0.01%. Regarding short-term risk, ESALY is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check KHTRF's competition here
ESALY vs PEXXF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, ESALY is priced at $61.51, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, ESALY's ROE is +0.06%, compared to PEXXF's ROE of N/A. Regarding short-term risk, ESALY is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check PEXXF's competition here
ESALY vs VRNOF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, VRNOF has a market cap of 450.4M. Regarding current trading prices, ESALY is priced at $61.51, while VRNOF trades at $1.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas VRNOF's P/E ratio is -1.26. In terms of profitability, ESALY's ROE is +0.06%, compared to VRNOF's ROE of -0.26%. Regarding short-term risk, ESALY is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check VRNOF's competition here
ESALY vs BOIRF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, BOIRF has a market cap of 416.7M. Regarding current trading prices, ESALY is priced at $61.51, while BOIRF trades at $24.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas BOIRF's P/E ratio is 31.58. In terms of profitability, ESALY's ROE is +0.06%, compared to BOIRF's ROE of +0.03%. Regarding short-term risk, ESALY is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check BOIRF's competition here
ESALY vs AGYTF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, AGYTF has a market cap of 405.1M. Regarding current trading prices, ESALY is priced at $61.51, while AGYTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas AGYTF's P/E ratio is -8.50. In terms of profitability, ESALY's ROE is +0.06%, compared to AGYTF's ROE of -13.93%. Regarding short-term risk, ESALY is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check AGYTF's competition here
ESALY vs HUMDF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HUMDF has a market cap of 404M. Regarding current trading prices, ESALY is priced at $61.51, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HUMDF's P/E ratio is -13.69. In terms of profitability, ESALY's ROE is +0.06%, compared to HUMDF's ROE of +2.11%. Regarding short-term risk, ESALY is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HUMDF's competition here
ESALY vs CRLBF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CRLBF has a market cap of 320.9M. Regarding current trading prices, ESALY is priced at $61.51, while CRLBF trades at $1.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CRLBF's P/E ratio is -6.79. In terms of profitability, ESALY's ROE is +0.06%, compared to CRLBF's ROE of -0.18%. Regarding short-term risk, ESALY is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check CRLBF's competition here
ESALY vs CPHRF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CPHRF has a market cap of 279.3M. Regarding current trading prices, ESALY is priced at $61.51, while CPHRF trades at $10.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CPHRF's P/E ratio is 30.28. In terms of profitability, ESALY's ROE is +0.06%, compared to CPHRF's ROE of +0.09%. Regarding short-term risk, ESALY is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check CPHRF's competition here
ESALY vs BHCCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, ESALY is priced at $61.51, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, ESALY's ROE is +0.06%, compared to BHCCF's ROE of +0.19%. Regarding short-term risk, ESALY is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check BHCCF's competition here
ESALY vs BIOIF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, BIOIF has a market cap of 204.2M. Regarding current trading prices, ESALY is priced at $61.51, while BIOIF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas BIOIF's P/E ratio is -0.02. In terms of profitability, ESALY's ROE is +0.06%, compared to BIOIF's ROE of -10.85%. Regarding short-term risk, ESALY is more volatile compared to BIOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check BIOIF's competition here
ESALY vs PLNHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, ESALY is priced at $61.51, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, ESALY's ROE is +0.06%, compared to PLNHF's ROE of -0.34%. Regarding short-term risk, ESALY is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check PLNHF's competition here
ESALY vs PHCUF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, PHCUF has a market cap of 156.6M. Regarding current trading prices, ESALY is priced at $61.51, while PHCUF trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas PHCUF's P/E ratio is -293.74. In terms of profitability, ESALY's ROE is +0.06%, compared to PHCUF's ROE of -0.01%. Regarding short-term risk, ESALY is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check PHCUF's competition here
ESALY vs CBWTF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CBWTF has a market cap of 154.4M. Regarding current trading prices, ESALY is priced at $61.51, while CBWTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CBWTF's P/E ratio is 5.75. In terms of profitability, ESALY's ROE is +0.06%, compared to CBWTF's ROE of +0.20%. Regarding short-term risk, ESALY is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check CBWTF's competition here
ESALY vs PLNH Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, PLNH has a market cap of 149.7M. Regarding current trading prices, ESALY is priced at $61.51, while PLNH trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas PLNH's P/E ratio is -3.29. In terms of profitability, ESALY's ROE is +0.06%, compared to PLNH's ROE of -0.32%. Regarding short-term risk, ESALY is less volatile compared to PLNH. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check PLNH's competition here
ESALY vs JUSHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, JUSHF has a market cap of 135.7M. Regarding current trading prices, ESALY is priced at $61.51, while JUSHF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas JUSHF's P/E ratio is -2.30. In terms of profitability, ESALY's ROE is +0.06%, compared to JUSHF's ROE of +1.20%. Regarding short-term risk, ESALY is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check JUSHF's competition here
ESALY vs COPHF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, ESALY is priced at $61.51, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas COPHF's P/E ratio is -0.02. In terms of profitability, ESALY's ROE is +0.06%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, ESALY is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check COPHF's competition here
ESALY vs AAWH Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, AAWH has a market cap of 130.7M. Regarding current trading prices, ESALY is priced at $61.51, while AAWH trades at $0.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas AAWH's P/E ratio is -1.53. In terms of profitability, ESALY's ROE is +0.06%, compared to AAWH's ROE of -1.05%. Regarding short-term risk, ESALY is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check AAWH's competition here
ESALY vs LOVFF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LOVFF has a market cap of 127.1M. Regarding current trading prices, ESALY is priced at $61.51, while LOVFF trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LOVFF's P/E ratio is 11.58. In terms of profitability, ESALY's ROE is +0.06%, compared to LOVFF's ROE of +0.15%. Regarding short-term risk, ESALY is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LOVFF's competition here
ESALY vs STMH Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, STMH has a market cap of 125.7M. Regarding current trading prices, ESALY is priced at $61.51, while STMH trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas STMH's P/E ratio is N/A. In terms of profitability, ESALY's ROE is +0.06%, compared to STMH's ROE of -2.75%. Regarding short-term risk, ESALY is more volatile compared to STMH. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check STMH's competition here
ESALY vs NWPN Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, ESALY is priced at $61.51, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas NWPN's P/E ratio is -0.04. In terms of profitability, ESALY's ROE is +0.06%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, ESALY is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check NWPN's competition here
ESALY vs GRUSF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, GRUSF has a market cap of 117.4M. Regarding current trading prices, ESALY is priced at $61.51, while GRUSF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas GRUSF's P/E ratio is -15.79. In terms of profitability, ESALY's ROE is +0.06%, compared to GRUSF's ROE of -0.89%. Regarding short-term risk, ESALY is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for ESALY.Check GRUSF's competition here
ESALY vs HLTRF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, HLTRF has a market cap of 116.2M. Regarding current trading prices, ESALY is priced at $61.51, while HLTRF trades at $3.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas HLTRF's P/E ratio is -6.49. In terms of profitability, ESALY's ROE is +0.06%, compared to HLTRF's ROE of -0.24%. Regarding short-term risk, ESALY is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check HLTRF's competition here
ESALY vs LPCUF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LPCUF has a market cap of 110.8M. Regarding current trading prices, ESALY is priced at $61.51, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LPCUF's P/E ratio is 18.82. In terms of profitability, ESALY's ROE is +0.06%, compared to LPCUF's ROE of +0.05%. Regarding short-term risk, ESALY is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LPCUF's competition here
ESALY vs CNVCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, ESALY is priced at $61.51, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, ESALY's ROE is +0.06%, compared to CNVCF's ROE of -3.90%. Regarding short-term risk, ESALY is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check CNVCF's competition here
ESALY vs BIOYF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, BIOYF has a market cap of 95.1M. Regarding current trading prices, ESALY is priced at $61.51, while BIOYF trades at $8.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas BIOYF's P/E ratio is 17.27. In terms of profitability, ESALY's ROE is +0.06%, compared to BIOYF's ROE of +0.22%. Regarding short-term risk, ESALY is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check BIOYF's competition here
ESALY vs LRDSF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, LRDSF has a market cap of 83.9M. Regarding current trading prices, ESALY is priced at $61.51, while LRDSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas LRDSF's P/E ratio is -0.01. In terms of profitability, ESALY's ROE is +0.06%, compared to LRDSF's ROE of +1.61%. Regarding short-term risk, ESALY is more volatile compared to LRDSF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check LRDSF's competition here
ESALY vs ABSCF Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, ABSCF has a market cap of 80.3M. Regarding current trading prices, ESALY is priced at $61.51, while ABSCF trades at $1.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas ABSCF's P/E ratio is -7.41. In terms of profitability, ESALY's ROE is +0.06%, compared to ABSCF's ROE of +0.32%. Regarding short-term risk, ESALY is more volatile compared to ABSCF. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check ABSCF's competition here
ESALY vs EOFBY Comparison August 2025
ESALY plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, ESALY stands at 17.6B. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, ESALY is priced at $61.51, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
ESALY currently has a P/E ratio of 20.54, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, ESALY's ROE is +0.06%, compared to EOFBY's ROE of N/A. Regarding short-term risk, ESALY is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for ESALY.Check EOFBY's competition here